过去一年中添加的文章，按日期排序

Use of tocilizumab to treat arthritis associated with mixed connective tissue disease complicated by ovarian teratoma: a case report

O Haruka, I Toru, M Ryosuke, T Hikaru, H Koji… - 日医大誌, 2024 - cir.nii.ac.jp
3 天前 - … <p>Mixed connective tissue disease (MCTD) is characterized by mixed features
of systemic lupus erythematosus, systemic sclerosis, and polymyositis/dermatomyositis and is …
相关文章

Francis R. Hopkins 1*, Johan Nordgren1

R Fernandez-Botran, H Enocsson… - Biology of C-reactive …, 2024 - books.google.com
3 天前 - … , inflammatory diseases such as rheumatoid arthritis (RA), and … as sepsis and
systemic lupus erythematosus, where an … inflammatory diseases such as rheumatoid arthritis (3), …
相关文章

CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models

D Li, S Shan, X Mao, Y Zhao, B Chen… - …, 2024 - Taylor & Francis
3 天前 - … exert ameliorative effects in rheumatoid arthritis. However, … Systemic lupus
erythematosus (SLE) is an autoimmune … is characterized as cutaneous lupus erythematosus …
相关文章 所有 2 个版本

Sexual dysfunction and self-perceived sexual health in patients with rheumatoid arthritis and systemic lupus erythematosus: results from a cross-sectional survey

G Serna-Peña, DP Flores-Gutierrez… - Rheumatology …, 2024 - Springer
3 天前 - … in patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE)
and … We performed a retrospective study in an outpatient rheumatology clinic to evaluate …
相关文章 所有 2 个版本

Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial

JT Merrill, Y Tanaka, D D'Cruz, K Vila‐Rivera… - … & Rheumatology - Wiley Online Library
4 天前 - Objective The 48‐week, phase 2 SLEek study (NCT03978520) evaluated the
efficacy and safety of upadacitinib (Janus kinase inhibitor) and elsubrutinib (Bruton's tyrosine …
相关文章 所有 2 个版本

Deciphering Autoimmune Diseases: Unveiling the Diagnostic, Therapeutic, and Prognostic Potential of Immune Repertoire Sequencing

Y Hu, J Huang, S Wang, X Sun, X Wang, H Yu - Inflammation, 2024 - Springer
4 天前 - … This article reviews the application and progress of IR-seq in diseases, such as
multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and type 1 diabetes, to …
相关文章 所有 2 个版本

A multiomic analysis to identify drivers of subclinical vascular disease in systemic lupus erythematosus

C Oliveira, Y Temesgen‐Oyelakin, M Naqi… - … & Rheumatology - Wiley Online Library
4 天前 - Background SLE increases cardiovascular disease (CVD) risk, not accounted by
traditional risk factors. Characterization of blood immunological signatures that associate with …
相关文章 所有 2 个版本

Single-cell analysis in rheumatic and allergic diseases: insights for clinical practice

M Nishide, H Shimagami, A Kumanogoh - Nature Reviews Immunology, 2024 - nature.com
5 天前 - … rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, allergic
airway diseases and atopic dermatitis, with an expanded scope beyond peripheral blood cells to …
相关文章 所有 2 个版本

Discovery of Novel Small Molecule Dual Inhibitor Targeting Toll-Like Receptors 7 and 9

M Haseeb, YS Choi, MC Patra, U Jeong… - Journal of Chemical …, 2024 - ACS Publications
8 天前 - … lupus erythematosus and rheumatoid arthritis. Toll-like receptor 7 (TLR7) and
TLR9, sequestered to the endosomal compartment of dendritic cells and macrophages, are …
相关文章

WNT16 as a promising biomarker for systemic lupus erythematosus and its role in regulating cell proliferation and apoptosis

K Wang, Y Jiang, J Zhai, P Zhang, Y Wu… - … rheumatology - pubmed.ncbi.nlm.nih.gov
10 天前 - … of the WNT family protein, in the context of systemic lupus erythematosus (SLE). …
), and disease controls comprised 154 individuals with rheumatoid arthritis (RA) and Sjögren's …
相关文章